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Abstract.  A  new cadherin-like protein (CLP) was 
identified in oocytes, eggs, and cleavage stage embryos 
of Xenopus laevis. As a probe for detecting new 
cadherin proteins, an antiserum was raised to a  17 
amino acid peptide derived from a highly conserved 
region in the cytoplasmic domain of all cadherins 
which have been sequenced to date. This antipeptide 
antibody recognized Xenopus E-cadherin and a poly- 
peptide in Xenopus brain extracts similar to N-cad- 
herin, which were independently identified by specific 
mAbs. In extracts of eggs and midblastula stage em- 
bryos the antipeptide antibody recognized specifically 
a  120-kD glycoprotein that migrated faster on SDS 
gels than the  140-kD E- and N-cadherin polypeptides. 
This  120-kD polypeptide was not recognized by the 
mAbs specific to E- and N-cadherin. In fact, E- and 
N-cadherin were not detectable in eggs or midblastula 
stage embryos. The possible relationship of CLP to 
P-cadherin,  which has been identified in mouse tis- 
sues, has not yet been determined. CLP was synthe- 
sized by large, late stage oocytes. When oocytes were 
induced to mature in vitro with progesterone it accu- 
mulated to the same level found in normally laid eggs. 
It did not accumulate further to any significant extent 
during the early cleavage stages.  CLP was detected on 
the surface of stage 8 blastomeres by cell surface 
biotinylation, but only after the tight junctions of the 
blastula epithelium were opened by removal of Ca  2+. 
We conclude that CLP is a  maternally encoded protein 
that is the major, if not only, cadherin-related protein 
present in the earliest stages of Xenopus development, 
and we propose that it may play a  role in the Ca  z+- 
dependent adhesion and junction formation between 
cleavage stage blastomeres. 
ARLY development in amphibians begins with the for- 
mation of the blastula, a ball of cells surrounding an 
internal cavity that is  sealed off from the outside 
medium by a tight surface epithelium (8). Cells of the blastu- 
la arise from a series of rapid, reductive cleavages of the egg. 
The development of intercellular adhesion between early 
blastomeres  and  the  formation of intercellular junctions 
seems to occur during the extension of the cleavage furrow 
(5,  6,  34).  In these early divisions the cleavage furrow is 
formed by the rapid addition of new cell surface membrane 
as a result of the exocytic fusion of stored intracellular vesi- 
cles (1,  34).  Presumably, intercellular adhesive structures 
are assembled from components stored in the egg as cleavage 
proceeds. Therefore, cleaving amphibian embryos provide a 
means to investigate the biogenesis and regulation of inter- 
cellular junctions occurring during the normal development 
of a simple epithelial tissue. 
All of the cells of the Xenopus blastula are linked together 
by a Ca2+-dependent adhesion mechanism (24).  In the sys- 
tems studied so far, the proteins underlying CaE+-dependent 
intercellular adhesion have been found to belong to the cad- 
herin family of adhesion molecules, including E-cadherin in 
epithelial tissues, N-cadherin in neural tissues, and P-cad- 
herin in placenta (9, 35).  In early mammalian embryos the 
first cadherin to  be  expressed  is  the  epithelial  cadherin, 
E-cadherin (also known as uvomorulin) (32, 39), and in the 
chick it is L-CAM (36), which is generally believed to be 
the same as E-cadherin. Since the Xenopus laevis blastula 
forms a  tight epithelium, it was expected that E-cadherin 
would be the first cadherin expressed, and that it would be 
stored in the egg ready for recruitment into the adhesive sur- 
faces of the cleaving blastomeres.  Surprisingly, we found 
that Xenopus E-eadherin was not detectable in eggs or early 
cleaving embryos (2).  E-cadherin did not begin to accumu- 
late until the beginning of gastrulation. Thus, the nature of 
the Ca2+-dependent  adhesion system in cleavage  embryos 
remained to be defined. 
We therefore asked whether another member of the cadhe- 
rin family of adhesion molecules, perhaps one that has not 
yet been identified, is expressed in the egg, the early cleavage 
stages, and the blastula of Xenopus laevis. The amino acid 
sequences of several different cadherin types in different spe- 
cies have been determined from cDNA clones (7,  14, 28). 
The cytoplasmic tail domain has regions of very high homol- 
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same cadherin in different  species.  We therefore  used anti- 
bodies raised to one of these conserved regions as a means 
to detect and identify cadherins in Xenopus eggs and early 
embryos. 
Materials and Methods 
Preparation of  Antigen and Generation of 
Antipeptide  Antibody 
A peptide corresponding to amino acid residues 665-681 derived from the 
chicken L-CAM eDNA sequence (7) with the addition of an NH2-terminal 
cysteine residue was designed by Gene Napolitano and Louis Reichardt at 
University of California, San Francisco and Sarah Crittenden at the Univer- 
sity of Wisconsin (Madison, WI) and generously provided to us to make 
the antipeptide antibody. The peptide was conjugated to the carrier protein, 
keyhole limpet hemocyanin, as described (18) (5 nag peptide/4.5 mg carrier 
protein) except that Sulfo-MBS (m-Maleimidobenzoyl-N-hydroxysuccinim- 
ide ester) (Pierce Chemical Co., Rockford, IL) was used instead of MBS. 
With this reagent the conjugation could be carded out entirely in aqueous 
solution. 
A  rabbit was immunized intradermally with the conjugated peptide in 
complete Freund's adjuvant in an amount equivalent to 0.5 nag of the free 
peptide. It was boosted 3 wk later with 0.5 mg peptide equivalents in incom- 
plete Freund's adjuvant injected subscapularly, another 3 wk later intramus- 
cularly with 0.5 mg peptide equivalents in PBS, 10 d later intramuscularly 
with 125 tLg peptide equivalents in PBS, and on days 1 and 2 thereafter with 
125 and 250 ttg peptide equivalents intravenously in PBS. 
Metabolic Cell Labeling, 1Issue  Sample Preparation, 
and lmmunoprecipitation 
A6 cells were cultured and labeled with [35S]methionine  as described (2). 
The cells were extracted with immunoprecipitation buffer (1% Triton X-100, 
0.5% Na deoxycholate, 0.2% SDS, 0.15 M NaCI, 20 mM Hepes pH 7.4) 
and supernatants were saved after centrifugation in a  microcentrifuge at 
10,000  rpm for 30 min. The supernatants were adjusted to 2% SDS, in- 
cubated for 30 rain at room temperature, diluted to 0.2% SDS with immu- 
noprecipitation buffer containing no SDS, and immunoprecipitated with 
3 #l of the antipeptide or the preimmune serum. Antibody-antigen com- 
plexes were precipitated with protein A-Sepharose as described (2). SDS- 
PAGE and fluorography were performed as described (2,  10). 
Extracts of Xenopus  tissues, including skin,  brain,  pericardium, and 
peritoneum were extracted as described (2). 
Handling of  Xenopus Eggs and Embryos and 
Preparation of  Samples 
Production of eggs, fertilization and removal of the jelly coat were done as 
described (22)  with minor modification. To obtain large numbers of em- 
bryos, frogs were allowed to lay eggs directly into MMR I (0.1 M NaCI, 2 
mM KCI,  1 mM MgSO4,  2  mM CaCI2,  5 mM Hepes, pH 7.8, 0.1  mM 
EDTA) before fertilization. Fertilization efficiency under these conditions 
was '~90%. Embryos were staged according to the normal table of Xenopus 
laevis development (23). 
Dejellied eggs or embryos were extracted with a 1:1 vol of 1% NP-40 in 
solution A (10 mM Hepes pH 7.4,  150 mM NaCI,  1.5 mM EDTA)  sup- 
plemented with protease inhibitors (1 mM PMSF, 0.5 mM iodoacetamide, 
1 #g/ml pepstatin A, 2 ~g/ml leupeptin, 4 ttg/ml aprotinin,  10 ttg/ml an- 
tipain, 50 ttg/ml benzamidine, 10 #g/ml soybean trypsin inhibitor) as de- 
scribed (2). The glycoproteins in the supernatant were enriched by binding 
to Con A-Sepharose-4B before immunoblotting assay. 
Cell Surface  Labeling 
Cell surface labeling of embryos with biotin was carried out by a modifica- 
tion of a published procedure (20, 31). NHS-LC-Biotin (sulfosuccinimidyl 
1. Abbreviations used in this paper: CLP, cadherin-derived protein; MBSH, 
modified Barth's saline containing  10 mM Hepes instead of Tris as the 
buffer; MMR, 0.1 M  NaCI, 2 mM KCI,  1 mM MgSO4, 2 mM CaCI2,  5 
mM Hepes, pH 7.8, 0.1  mM EDTA. 
6-(biotinamido) hexanoate; Pierce Chemical Co.) was used instead of  Sulfo- 
NHS-biotin (sulfosuccinimidobiotin) because it dissolved readily in aque- 
ous solution without prior preparation as a stock solution in dimethyl sulf- 
oxide. Labeling was done on ice for 30 rain in 1 mg/ml NHS-LC-Biotin in 
the appropriate buffer (below). Labeling was quenched by rinsing embryos 
or blastomeres three times in buffer containin~ 10 mM [glycine. 
To label embryos, the jelly coat was removed after fertilization and em- 
bryos were transferred into a 1:10 concentration of MMR to allow develop- 
ment to proceed. A little over 200 embryos were labeled in each condition. 
Fertilized eggs that had raised fertilization envelopes but had not yet begun 
to cleave were labeled in MMR. Intact blastulae at stage 8 were transferred 
to MMR at room temperature for 20 min and then labeled in MMR. An- 
other set of blastulae were rinsed three times and incubated for 20 min at 
room temperature in a Ca2+-free buffer (0.1 M Na isethionate, 20 mM Na 
pyrophosphate, 20 mM glucose, pH 8.5) to open the tight junctions and al- 
low access of labeling reagent to the internal blastomere cell surfaces. Be- 
cause blastomeres were constrained by the fertilization envelope, they did 
not dissociate completely as previously reported (22), but were observed 
under the stereomicroscope to become somewhat rounded. Labeling was 
performed in the Ca2+-free buffer adjusted to pH 7.8. As a control another 
set of embryos was lysed directly into Ca2+-free buffer containing 1 mg/ml 
NHS-LC-biotin by repeated pipeting through a  1-ml pipet tip. In this ease 
it was not possible to quench the reaction by rinsing in 10 mM glycine. 
After labeling and quenching was complete, embryos or blastomeres 
were extracted with a 2:1 volume of 1% NP-40 in solution A with the pro- 
tease inhibitors and cadherin-like protein (CLP) was immunopreeipitated 
with the antipeptide antibody (overnight incubation) as described above. Bi- 
otinylated proteins were detected after their separation by SDS-PAGE and 
transfer to nitrocellulose by blotting with alkaline phosphatase-conjugated 
avidin using a Vectastain kit from Vector Laboratories (Burlingame, CA). 
In Vitro  Maturation and Biosynthetic  Labeling 
of Oocytes 
A mature female frog was anesthetized with 0.3% ethylaminobenzoate in 
the bath water and its ovary was dissected out. Oocytes were prepared as 
described (4). The sheet of ovary was cut into small pieces and most of the 
blood was washed away with modified Barth's saline (11) containing 10 mM 
Hepes instead of Tris as the buffer (MBSH). Oocytes were dissociated from 
follicle cells by treatment with 150 nag type IA coilagenaseJovary (Sigma 
Chemical Co.,  St.  Louis, MO).  The collngenase was first desalted and 
equilibrated with MBSH before use. Digestion of follicle cells occurred for 
2-3 h at room temperature with gentle shaking. The completion of  digestion 
was determined by looking in a stereomicroscope for the disappeauance of 
the red-colored follicle cells from the surface of the oocytes. After washing 
off collagenase with MBSH, large oocytes were separated from small oo- 
cytes by allowing them to settle against an upward flow of medium. 
In vitro maturation of oocytes was performed as described (4). Oocytes 
were incubated in 5/~g progesterone (Sigma Chemical Co.) per milliliter 
in MBSH (added from a stock solution of I nag progesteronc/ml ethanol) 
for 5 h at room temperature. The completion of maturation was determined 
by the appearance oft white spot on the animal cap and by germinal vesicle 
breakdown. Disappearance of the germinal vesicle within the internal side 
of the animal pole was determined using a stereomicroscope after fixing a 
sample of oocytes in 10% TCA for 5 rain and cutting them in balf horizon- 
tally with a watchmakers forceps. After maturation, oocytes were incubated 
in progesterone-free  MBSH for different  periods of  time for up to 20 h. Con- 
trol oocytes were incubated in 5/~1 ethanoi/mi MBSH for 5 h. 
For the biosynthetic labeling of oocytes, ,~100 oocytes were incubated 
in  1  mCi  of [35S]methionine  during  the progesterone treatment.  After 
maturation, oocytes were washed several times with MBSH, extracted with 
1% NP-40 in solution A containing the proteas¢ inhibitors and immunopre- 
cipitated with the antipeptide antibody as described above. 
Anticadherin Antibodies  and lmmunobiotting 
A  mixture of four independent mAbs against Xenopus  E-cadherin, de- 
scribed previously (2), were used in all immunoblotting experiments. Anti- 
Xenopus E-cadherin mAbs 8C2 and 5D3 were subclass IgGl, while mAbs 
19A2 and 31D2 were subclass IgG2b. mAbs 5D3 and 19A2 recognize both 
the +Ca  z+ and the -Ca  2+ conformations of E-cadberin, while mAbs 8C2 
and 31D2 recognize only the -Ca  2+ conformation (2). The mAb NCD-2 
to chicken N-cadherin (12) was a gift of M. Takeichi  (Kyoto University, 
Kyoto, Japan). Alkaline phosphatase-conjugated goat anti-rabbit IgG and 
anti-mouse IgG  (Bio-Rad  Laboratories,  Richmond,  CA),  and  alkaline 
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cadherin peptide antibody. (A) lmmunoblot  analysis of SDS ex- 
tracts of A6 cell. Anti-E-cadherin mAb (lane a); antipeptide anti- 
body  (lane b);  antipeptide  antibody  preincubated  with  30  /~g 
cadherin-derived peptide (lane c); preimmune serum (lane d). (B) 
Immunoprecipitation of extracts of [35S]methionine-labeled  cells. 
Anti-E-cadherin  mAb (lane a); antipeptide antibody (lane b); an- 
tipeptide antibody preiticilbated with 30/zg cadherin-derived pep- 
tide (lane c); preimmune serum (lane d). 
phosphatase-conjugated  rabbit anti-rat IgG (Miles Laboratories  Inc., Elk- 
hart, IN) were used as second antibodies to detect rabbit, mouse, and rat 
antibodies, respectively.  SDS-PAGE  and immunobiotting  were performed 
as described  (2, 10). Pro~ins  were  separated  on 8% polyacrylamide/0.21% 
bis-acrylamide gels under denaturing conditions. Prestained molecular 
mass markers  (Sigma  Chemical  Co.) were  used  for the molecular  mass esti- 
mation  of  proteins. Proteins  were  electrophoretically  transferred  to nitrocel- 
lulose and immunobiotted. 
tide against which it was made (lane c). The antibody also 
immunoprecipitated a biosynthetically labeled 140-kD poly- 
peptide from detergent extracts of A6 cells (Fig.  1 B, lane b) 
just like the mAbs to E-cadherin (lane a). Again, the E-cad- 
herin-sized polypeptide was not recognized by preimmune 
serum or by the antipeptide antibody treated with excess pep- 
tide (Fig.  1 B, lanes c and d, respectively). 
A polypeptide of,x,120 kD not recognized by the mAbs to 
E-cadherin was recognized by the antipeptide antibody, both 
by immunoblotting and by immunoprecipitation (Fig.  1 A, 
lane b,  and B, lane b).  The reactivity was specifically in- 
hibited by excess cadherin-derived peptide, and therefore is 
likely to contain portions of the cadherin cytoplasmic tail se- 
quence. It is possible that this polypeptide is a cadherin gene 
product distinct from E-cadherin which is coexpressed in the 
A6 cell line (see Discussion). 
Fig. 2 demonstrates that the antipeptide antibody recog- 
nizes the very same 140-kD polypeptide as mAbs to E-cad- 
herin. When E-cadherin was immunoprecipitated with the 
anti-E-cadherin mAbs it was recognized with the antipeptide 
antibody by immunoblotting (Fig.  2,  lane a),  Conversely, 
when immunoprecipitation was first carried out with the an- 
tipeptide antibody, E-cadherin was detected by immunoblot- 
ting  with the mAbs  (Fig.  2,  lane c).  E-cadherin was  not 
detected by immunoblotting with either antibody when pre- 
immune serum was used in the immunoprecipitation step 
(Fig. 2, lanes b and d). Therefore, the antipeptide antibody 
specifically reacted with E-cadherin of Xenopus laevis.  Re- 
Results 
Recognition of Xenopus Cadherins by the 
Antipeptide Antibody 
An antiserum raised in rabbits against a peptide correspond- 
ing to amino acid residues 665-681 derived from the chicken 
LCAM cDNA sequence (7) was found to recognize cadherin 
polypeptides in cells and tissues from Xenopus laevis. In im- 
munoblot analysis of extracts of the A6 Xenopus  epithelial 
cell line (Fig.  1 A) this antiserum bound with high titer to 
a  140-kD polypeptide (lane b) as do mAbs to E-cadherin 
(lane a). A major 116-kD degradation product of  E-cadherin 
was recognized by the mAbs to E-cadherin, which bind to 
the ectoplasmic domain of the protein (Fig. 1 A, lane a), but 
was not recognized by the antipeptide antibody (Fig.  1 A, 
lane b).  Presumably this  fragment had been cleaved away 
from the cytoplasmic tail, which harbors the epitopes recog- 
nized by the antipeptide antibody. 
The specificity of the binding of the antipeptide antibody 
to the 140-kD polypeptide was demonstrated by the absence 
of binding of the preimmune serum (Fig.  1 A, lane d) and 
by the inhibition of the binding of the immune serum after 
it was incubated with an excess of the cadherin-derived pep- 
Figure 2. Antipeptide antibody and mAbs to Xenopus E-cadherin 
recognize the same polypeptide in A6 cells. Extracts of unlabeled 
A6 cells were immunopreeipitated with either a mAb to Xenopus 
E-cadherin  (lane a),  the antipeptide antibody  (lane c), or with 
preimmune serum (lanes b and d). After separation on an SDS gel 
the immunoprecipitates were analyzed by immunoblotting either 
with the antipeptide antibody (lanes a and b) or with the mAb to 
E-cadherin (lanes c and d). 
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sues. Extracts of brain (lanes a and b), peritoneum (lanes c and d), 
and skin (lanes e and f) were immunoblotted with 1:500 dilution 
of the polyclonal serum against the peptide (lanes a, c, and e), with 
the mAb NCD-2 against chicken N-cadherin (lane b), and with the 
hybridoma supernatants against Xenopus E-cadherin (lanes d and 
f). Numbers at left are molecular mass markers in kiiodaltons. 
probable that the 140-kD polypeptide recognized by the an- 
tipeptide antibody is N-cadherin. In addition to the 140-kD 
polypeptide, the antipeptide antibody also bound a  120-kD 
polypeptide in brain that was not detected by mAb NCD-2. 
An attempt was made to determine whether the antipep- 
tide antibody recognized P-cadherin in Xenopus. Unfortu- 
nately, it is not yet possible to unambiguously detect P-cad- 
herin in Xenopus tissues, because cross-reacting antibodies 
are not available and because Xenopus does not have a pla- 
centa, the major source of P-cadherin in mouse (25). In the 
mouse, P-cadherin is also expressed in the mesothelium as 
well as in the epidermis (15, 17), and therefore these tissues 
were examined as a potential source of P-cadherin in Xeno- 
pus (Fig.  3, lanes c-f).  In a combined extract of the peri- 
toneal membrane and the pericardium as a source of meso- 
thelium, the antipeptide antibody (Fig.  3,  lane c) and the 
anti-E-cadherin mAb (lane d) both immunoblotted a major 
polypeptide of 140 kD.  This reactivity probably represents 
the presence of E-cadherin in these tissues. Like A6 cells and 
brain, a minor 120-kD polypeptide was detected by the an- 
tipeptide antibody but not by the mAbs to E-cadherin. In an 
extract of Xenopus skin both antibodies recognize a  140-kD 
potypeptide (Fig. 3, lanes e and f), which again is probably 
due  to  the presence of E-cadherin.  The lower molecular 
mass bands in Fig. 3, lane fare probably degradation prod- 
ucts of E-cadherin in  skin.  Because these tissues  express 
high levels of E-cadherin it is questionable to use them as 
activity with canine E-cadherin in MDCK cells was also ob- 
served (not shown). 
The epitope formed by the conserved cytoplasmic domain 
represented by the peptide seems to be masked in the "native" 
state and requires denaturation to be recognized by the an- 
tipeptide antibody. Despite the high level of reactivity of the 
antipeptide antibody against denatured E-cadherin, the anti- 
body staining of E-cadherin could not be detected in A6 cells 
by indirect immunofluorescence (not shown). This contrasts 
the intense staining of E-cadherin observed in A6 cells using 
the mAbs directed against the ectoplasmic domain of the 
protein (2).  Similarly, the antipeptide antibody could not 
immunoprecipitate E-cadherin from nonionic detergent ex- 
tracts  of A6  cells  (not  shown).  For  immunoprecipitation 
(Fig.  1 B) it was necessary to first denature the cell extract 
in  SDS.  It is  possible that this conserved amino acid se- 
quence is masked by the binding of the "catenins; three cy- 
toplasmic polypeptides that  form a  protein complex with 
E-cadherin by binding to its cytoplasmic tail (26). 
The antipeptide antibody probably also recognizes other 
cadherin polypeptides in tissues of Xenopus laevis (Fig.  3, 
lanes a,  c, and e). N-cadherin was identified as a  140-kD 
polypeptide in extracts of Xenopus brain with mAb NCD-2 
to chicken N-cadherin (Fig. 3, lane b). The same-sized poly- 
peptide in Xenopus brain was detected by the antipeptide an- 
tibody (Fig. 3, lane a). Since significant amounts of E-cad- 
herin were not found previously in Xenopus brain (2), it is 
Figure 4. Identification of a novel CLP in Xenopus eggs and em- 
bryos. Extracts of * 200 Xenopus eggs (lanes a-c) and embryos at 
midblastula stage (lanes d-f) were enriched for glycoproteins by 
binding to Con A-Sepharose and then immunoblotted with the an- 
tipeptide antibody against the cadherin-derived peptide at a dilution 
of 1:500 (lanes a and d); a monoclonal antibody against chicken 
N-cadherin (NCD-2) (lanes b and e); and a mixture of monoclonal 
antibodies (5D3, 8C2, and 19A2)  against Xenopus E-cadherin (lanes 
c and  f). Numbers at left are molecular mass markers in kilodaltons. 
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kD band in peritoneum recognized by the antipeptide anti- 
body is a possible candidate, but amino acid sequence data 
or a specific antibody will be necessary to definitively iden- 
tify Xenopus P-cadherin in any tissue. 
Identification of  a CLP in Oocytes, Eggs, and 
Cleaving Embryos 
To determine whether a cadherin protein exists that could ac- 
count for the Ca~÷-dependent adhesion between early Xeno- 
pus blastomeres, glycoprotein enriched fractions of extracts 
of eggs and cleavage staged embryos were analyzed by im- 
munoblotting with the various anticadherin antibodies. The 
antipeptide antibody effectively detected a  major polypep- 
tide of 120-kD in both eggs and midblastula stage embryos 
(Fig. 4). It also recognized variably minor polypeptides of 
slightly higher molecular mass. None of these polypeptides 
were detected with the preimmune serum (not  shown) or 
when the antipeptide antibody was incubated with an excess 
of the cadherin-derived peptide (Fig. 6). Therefore, the ma- 
jor  120-kD polypeptide and minor higher molecular mass 
bands contain an epitope, and presumably an amino acid se- 
quence, in common with all the known cadherins. 
The 120-kD CLP and higher molecular mass polypeptides 
in eggs and midblastula embryos do not seem to be either 
E- or N-cadherin. As observed previously (2), neither eggs 
nor midblastula stage embryos contained detectable amounts 
of E-cadherin (Fig. 4, lanes c and f). The absence of detect- 
able E-cadherin epitopes could not be attributable to proteo- 
lytic degradation, because exogenous E-cadherin from A6 
cells added to egg homogenates could be completely recov- 
ered in immunoblots (data not shown). Also, mAb NCD-2, 
which recognizes N-cadherin (Fig.  3), failed to recognize 
the  120-kD cadherin or the minor higher molecular mass 
polypeptides (Fig. 4, lanes b and e). Whether the variably 
observed higher molecular mass polypeptides are precursors 
or modifications of CLP, or represent additional minor cad- 
herin gene products remains to be determined. 
We wished to know whether the time of  expression of CLP 
is consistent with it having a function in the egg and/or cleav- 
ing embryo, rather than, for example, being a remnant left 
over from the interaction between the oocyte and the follicle 
cells. Oocytes were prepared from follicular tissue by col- 
lagenase treatment to insure that the follicle cells had been 
removed. In immunoblots of extracts of large, late stage oo- 
cytes that had been incubated overnight in vitro in saline, 
CLP was present at low but detectable levels (Fig. 5 A, lane 
a). When the same batch of oocytes was induced to mature 
with 5-h progesterone treatment and then incubated over- 
night in vitro, the CLP polypeptide accumulated to the same 
levels (Fig. 5 A, lane b) as it is found in naturally laid eggs 
(lane c). The biosynthesis of  the CLP polypeptide by oocytes 
was confirmed by immunoprecipitating a denatured extract 
of oocytes that had been labeled with  [35S]methionine  for 
5 h (Fig. 5 B). A biosynthetically labeled 120-kD polypep- 
tide  was  immunoprecipitated by the  antipeptide  antibody 
(Fig. 5 B, lanes a  and c), but not in the presence of excess 
cold cadherin-derived peptide (lane b). These results show 
that CLP is synthesized by late stage oocytes, and that its ac- 
cumulation to the levels found in the egg is dependent on 
maturation induced by progesterone. 
Figure 5. CLP expression in oocytes and dependence on progester- 
one-induced maturation. (A) Levels of CLP expression in proges- 
terone-treated and untreated oocytes at 20 h maturation in vitro. 
Oocytes were incubated for 5 h with (lane b) or without (lane a) 
5/~g/ml progesterone and subsequently incubated in MBSH free of 
progesterone for 20 h. About 200 oocytes from each were extracted 
and immunoblotted with a  1:500 dilution of the antipeptide anti- 
body. For comparison an extract of 200 eggs was also immuno- 
blotted with the same serum (lane c). (B) Biosynthetic labeling of 
CLP polypeptides. Oocytes were labeled with 1 mCi of [35S]me- 
thionine for 5 h with (lane c) or without (lane a) progesterone. Ex- 
tracts were SDS- and heat-denatured, and immunoprecipitated with 
the antipeptide antibody (lanes a and c) or with the antipeptide an- 
tibody after preincubation with 30 #g cadherin-derived  peptide 
(lane b). 
Progesterone did not greatly increase the extent of biosyn- 
thetic labeling of CLP during the first 5 h of treatment (Fig. 
5 B, lane c vs. lane a). By immunoblot analysis CLP was ob- 
served to accumulate gradually overnight after progesterone 
induction (data not shown). The accumulation of CLP dur- 
ing overnight incubation could result either from a gradual 
increase in its biosynthesis after completion of the 5-h matu- 
ration process or from a decrease in its rate of turnover. 
Intercellular adhesion first becomes required in Xenopus 
embryogenesis during the cleavage stages (24).  Therefore, 
it was of interest to determine whether the levels of CLP 
changed during the cleavage stages of development. By the 
criterion of semiquantitative immunoblotting, the levels of 
CLP increased only slightly during the cleavage stages (Fig. 
6,  lanes a-e). The higher molecular mass minor polypep- 
tides became more prominent during cleavage.  Their sig- 
nificance is not clear because their relationship to CLP is un- 
known.  These findings along with the oocyte biosynthesis 
data demonstrate that the time of  greatest CLP accumulation 
is during the maturation of the oocyte to the egg, with little 
change in levels occurring during the early cleavage stages. 
Localization of CLP in Eggs and Blastulae 
If CLP is involved in adhesion between early blastomeres, 
it should be expressed at the blastomere surface,  but not 
present at the outer cortical membrane surface of the egg. 
Cell surface localization was analyzed by labeling with the 
membrane impermeable protein biotinylating reagent, NHS- 
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ofXenopus laevis. Extracts of ",,200 eggs (lanes a  and f) or em- 
bryos at 2 (lanes b and g), 4 (lanes c and h), 6 (lanes d and i), and 
7 h (lanes e and  j) after fertilization were immunoblotted with 1:500 
dilution of the antipeptide antibody (lanes a-e) and the same serum 
after preincubation  with  30  #g  of the  cadherin-derived  peptide 
(lanes f-j).  Numbers at left are molecular mass markers in kilo- 
daltons. 
probe for detecting a  wide variety of cadherins  in different 
species. Although raised to a peptide sequence derived from 
the known chicken and mouse cadherins,  it specifically rec- 
ognized cadherins  in tissues of Xenopus  laevis.  The antise- 
rum bound to E-cadherin in extracts of cultured A6 cells, and 
of Xenopus skin and peritoneum; it also bound to a polypep- 
tide in Xenopus brain extracts that had the same molecular 
size as N-cadherin.  The specificity of the antiserum for the 
cadherin  sequence  was readily demonstrated by the inhibi- 
tion of its binding to E-cadherin with an excess of the peptide 
against which it was raised.  These findings suggest that the 
antipeptide  antibody  is capable of recognizing  members of 
the cadherin family of proteins in tissues of Xenopus  laevis. 
Similar conclusions have been reached from observations by 
L.  Reichardt,  J.  Lilien,  and their co-workers examining in- 
dependently derived antisera to the same peptide (Reichardt, 
L., personal communication). Therefore, this antibody might 
be expected to be a suitable reagent for the identification of 
new members of the cadherin family of proteins in Xenopus. 
LC-biotin (20, 31). Embryos were labeled with biotin through 
their  fertilization  envelopes  (Fig.  7).  Either  fertilized  eggs 
(Fig. 7, lanes a  and a'), intact stage 8 blastulae (lanes b and 
b'), or stage 8 blastulae with opened intercellular junctions 
(lanes c and c') were labeled. Detergent extracts of embryos 
were  immunoprecipitated  with  the  antipeptide  antibody 
(Fig.  7, lanes a, b, c, and d) or preimmune serum (lanes a', 
b', c', and d'), and biotinylated proteins were detected by blot- 
ting with avidin.  Significant labeling of a  120-kD polypep- 
tide occurred  in blastulae that had  been incubated  in Ca  2+- 
free medium to open the tight junctions of the surface epithe- 
lium (Fig.  7, lane c).  The absence of this polypeptide in the 
preimmune control  (Fig.  7,  lane c') indicates  that  it repre- 
sents  labeling  of CLP. 
Greatly reduced labeling of CLP was observed in blastulae 
with  intact  tight junctions  (Fig.  7,  lane b).  No  labeling  of 
CLP was detected when fertilized eggs, before first cleavage, 
were  biotinylated  (Fig.  7,  lane  a).  The  reduction  in  CLP 
labeling in these samples was not due to poor biotinylation, 
because the total Con-A-binding  glycoproteins of the three 
samples were biotinylated to similar extents (data not shown). 
As an additional  control,  embryos were intentionally  lysed 
in the labeling medium by vigorous pipetting  (Fig.  7,  lanes 
d and d').  Little, if any, CLP was labeled in lysed embryos. 
These results together demonstrate that CLP was labeled in 
Ca2+-free treated blastulae due to its expression at the blas- 
tomere surface, and not due to artifactual labeling after cell 
lysis or from permeation of the reagent through the plasma 
membrane.  Moreover, these results suggest that CLP in the 
egg is present in an intracellular pool, and when it becomes 
expressed at the blastomere plasma membrane, it is localized 
to the internal  cell  surfaces that face the blastocoel  cavity. 
Discussion 
The antipeptide serum used in this study seems to be a good 
Figure 7.  Cell surface biotinylation of CLP in Xenopus embryos. 
Lanes a  and a', embryos were biotinylated  1 h after fertilization, 
after the raising of the fertilization envelope but before first cleav- 
age; lanes b  and b',  stage 8 embryos were biotinylated in Ca  2+- 
containing medium to keep tight junctions  intact; lanes c and c', 
stage 8 embryos were incubated in Ca2+-free buffer at room tem- 
perature before biotinylation in order to open the tight junctions; 
lanes d  and d',  stage  8  embryos were  lysed in Ca2+-free buffer 
containing the biotinylation reagent. The IgG contains so much bio- 
tin because the unquenched  NHS-LC-biotin remained during the 
immunoprecipitation and because it is the major protein recovered 
in the immunoprecipitate. For each sample, •200  ~l of labeled em- 
bryos were extracted  with detergent-containing  buffer,  of which 
half was immunoprecipitated with the antipeptide antibody (a, b, 
c, and d) and half with the preimmune serum (a', b', c', and d'). 
Immunoprecipitates were separated by SDS-PAGE and transferred 
to nitrocellulose, and biotin-containing proteins were detected with 
alkaline phosphatase-conjugated avidin. 
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identity in oocytes, eggs, and cleavage stage embryos. CLP 
seems to be the major, if not only, protein expressed in cleav- 
age stage embryos that harbors the highly conserved cadhe- 
rin sequence recognized by this antibody. Because neither 
E-cadherin nor N-cadherin are expressed at these stages, 
CLP is a very good candidate to be the cadherin that medi- 
ates Ca2+-dependent adhesion in the blastula. Unfortunate- 
ly, it has not yet been possible to use another established 
criterion for identifying cadherins, the characteristic protec- 
tion of the ectoplasmic domain from trypsin degradation by 
the presence of calcium ions (10, 16, 33, 38). In the absence 
of Ca  2÷  the ectoplasmic domain is extensively degraded, 
but in the presence of Ca  2÷ most of it is cleaved from the 
cell surface in a soluble form that is resistant to further pro- 
teolysis. It has not been possible to use the antipeptide anti- 
body, which recognizes the cytoplasmic tail domain, to dis- 
tinguish between degradation or release of the ectoplasmic 
domain. However, because CLP was detected with an anti- 
body raised against a specific cadherin consensus sequence 
that recognizes known cadherins in Xenopus tissues, we be- 
lieve that it is likely to be a maternally encoded member of 
the cadherin family of proteins. Eventually the amino acid 
sequence of CLP determined from its cDNA clone will re- 
veal its overall relatedness to the other cadherins. 
The presence of CLP in eggs and cleaving embryos could 
account, at least in part,  for the Ca2+-dependent  adhesion 
system that has been shown to be present in early Xenopus 
blastomeres (24).  However, we do not yet have experimental 
evidence that this protein  functions in adhesion between 
early blastomeres. The usual adhesion assays have not yet 
been performed because the antipeptide antibody recognizes 
the cytoplasmic tail of CLP only under denaturing condi- 
tions.  However,  several  properties  of CLP are  consistent 
with it being an adhesion molecule. It is a glycoprotein, since 
it binds to the lectin Con-A, and it is expressed at the cell 
surface, since it can be labeled by a membrane impermeable 
reagent. The inaccessibility of CLP to surface labeling in 
intact blastulae indicate that it is expressed on the internally 
disposed surface of the blastomeres, which would be ex- 
pected to participate in cell-to-cell contacts. To determine 
whether CLP participates  in Ca2+-dependent adhesion events, 
additional antibodies raised to the extracellular portion of 
the protein will again be required. 
The increase in CLP expression during meiotic maturation 
is most likely an  indirect posttranseriptional response to 
progesterone.  Progesterone-induced maturation is a  com- 
plex process that begins with the activation of a cell surface 
receptor and involves many cellular events which lead to ger- 
minal vesicle breakdown (GVBD)  (21,  29).  The increased 
expression of  oocyte proteins during maturation results from 
translational  regulation of stored  maternal  mRNAs  by  a 
mechanism involving mRNA recruitment onto polysomes 
(27).  The early induction of a small number of proteins, in- 
cluding the c-mos protooncogene, is required for meiotic 
maturation and GVBD  (30).  Quantitatively, however,  the 
greatest hormone-induced increase in protein synthesis oc- 
curs after GVBD (21, 27).  These "late" proteins, including 
for example the histones, are believed to be destined to func- 
tion in later stages of development. CLP expression is simi- 
lar  to  the  late-induced proteins,  because  it  accumulates 
gradually after progesterone-induced maturation and its rate 
of biosynthesis does not increase significantly during the ini- 
tial 5-h period of progesterone treatment. Although we have 
not ruled out regulation of CLP expression by a decrease in 
its rate of turnover, the similarity of its pattern of expression 
to that of the known late-induced proteins suggests that its 
expression is regulated at the level of translation. Therefore, 
it is likely that CLP plays a role in the egg and/or early stages 
of  development  before  the  onset  of  zygotic  gene  tran- 
scription. 
It is possible that CLP is a new member of the cadherin 
family distinct from all other previously identified cadhe- 
rins. In the present study we have demonstrated that CLP is 
distinct from E-cadherin and N-cadherin by its molecular 
size and by its lack of reactivity with mAbs to E- and N-cad- 
herin. Moreover, it is not a degradation product of E-cad- 
herin, the first cadherin species to be expressed in other or- 
ganisms (2). It is possible, however, that CLP is the Xenopus 
equivalent of P-cadherin, since it has not yet been possible 
to identify P-cadherin in Xenopus. It is also conceivable that 
CLP corresponds to a protein in Xenopus laevis  that is recog- 
nized by antibodies to chicken L-CAM. In contrast to mAbs 
to Xenopus E-cadherin (2),  antibodies to chicken L-CAM 
detected a polypeptide of •120  kD in Xenopus skin and a 
very weak immunohistological reactivity in blastula stage 
embryos (19). IfCLP is distinct from the other known cadhe- 
rin proteins, it could either be the product of  a distinct cadhe- 
rin gene or arise from posttranscriptional processing of a 
known cadherin gene. To determine the definitive relation- 
ships between CLP and other known cadherins the genera- 
tion of additional antibodies specific to Xenopus CLP and/or 
the cloning of several  of the Xenopus cadherin cDNAs will 
be required. 
CLP may be present along with other cadherins in tissues 
other than the egg or the blastula. In the A6 kidney cell line, 
the brain, and perhaps mesothelial tissues, the anticytoplas- 
mic tail peptide antibody specifically recognized polypep- 
tides of ~120  kD that were not recognized by mAbs to 
E-cadherin or N-cadherin. The similarity of their molecular 
sizes on SDS gels to CLP raises the possibility that they are 
all the same protein. Such a conclusion is premature, how- 
ever, because the antipeptide antibody has a broad specificity 
for most, if not all, cadherins. Coexpression of two different 
cadherins in one cell type would not be surprising, since the 
expression of multiple cadherins has been observed, espe- 
cially in developing tissues (13, 15,  17, 35). 
In some experiments minor bands of a slightly lesser mo- 
bility on SDS gels were resolved from the major 120 kD 
CLP polypeptide. These polypeptides might represent bio- 
synthetic precursors  or posttranslational modifications of 
CLP. Larger biosynthetic precursors having an NHe-termi- 
nal propeptide have been observed for all the known cadhe- 
rins (2, 3, 14), and at least E-cadherin and L-CAM are known 
to be phosphorylated on serine residues (3, 37, 40). Again, 
the broad specificity of the antipeptide antibody makes it 
difficult to know the relationship between all of these poly- 
peptides. It is clear, however, that these bands are not recog- 
nized by mAbs to E- and N-cadherin. Specific probes for 
CLP and pulse-chase metabolic labeling experiments will 
enable us to examine whether they are metabolically related 
to CLP, or whether they represent yet additional cadherin 
species in Xenopus. 
We propose that CLP is present in the Xenopus egg for the 
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thelial  junction  formation  between  early  cleavage stage 
blastomeres. Our findings suggest that CLP is synthesized by 
the oocyte during its maturation to a fertilizable egg and is 
stored in the egg for use during early development. Prelimi- 
nary experiments indicate that CLP is present in the egg in 
intracellular vesicles  (unpublished observations).  Recruit- 
ment of CLP-containing vesicles to the internal blastomere 
surfaces  could  occur  by  their  fusion  with  the  advancing 
cleavage furrow. Fusion of stored vesicles with the advancing 
cleavage furrow has been observed by electron microscopy 
(1, 34). Further experiments on the structure and function of 
CLP and the mechanism of its recruitment into the blasto- 
mere cell surface may yield insights into the biogenesis and 
regulation of adhesive junctions  during embryonic  devel- 
opment. 
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